Last reviewed · How we verify
Spiolto® Respimat®
Spiolto® Respimat® is a Small molecule drug developed by Boehringer Ingelheim. It is currently FDA-approved. Also known as: INSPIOLTO, SPIOLTO, STIOLTO, VAHELVA, YANIMO, LABA/LAMA.
Spiolto Respimat is a medication used to treat Chronic Obstructive Pulmonary Disease (COPD). It contains a combination of tiotropium and olodaterol, which are delivered via a Respimat inhaler.
At a glance
| Generic name | Spiolto® Respimat® |
|---|---|
| Also known as | INSPIOLTO, SPIOLTO, STIOLTO, VAHELVA, YANIMO, LABA/LAMA |
| Sponsor | Boehringer Ingelheim |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects (PHASE1)
- A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler
- Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Olodaterol Fixed Dose Combination in Greece
- Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)
- Effects of Spiolto® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects (PHASE4)
- Cardiac Effects of Spiolto®/Respimat® in Patients With Congestive Heart Failure and COPD (PHASE4)
- Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE] (PHASE4)
- Re-usable Respimat® Soft MistTM Inhaler Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Spiolto® Respimat® CI brief — competitive landscape report
- Spiolto® Respimat® updates RSS · CI watch RSS
- Boehringer Ingelheim portfolio CI
Frequently asked questions about Spiolto® Respimat®
What is Spiolto® Respimat®?
Who makes Spiolto® Respimat®?
Is Spiolto® Respimat® also known as anything else?
What development phase is Spiolto® Respimat® in?
Related
- Manufacturer: Boehringer Ingelheim — full pipeline
- Also known as: INSPIOLTO, SPIOLTO, STIOLTO, VAHELVA, YANIMO, LABA/LAMA
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing